12 February, 2019

Develop new medicines, make them accessible in a sustainable environment and attract investments to the country, objectives of the pharmaceutical industry in Spain

Source: Investigate and develop new medicines more and more precise and effective, facilitate the access of patients to these innovative drugs in an environment of […]
22 January, 2019

The Carlos III Health Institute announces new European calls for research

Source: The Health Institute Carlos III (ISCIII) has announced that, through European programs, has “about five million euros” to participate in the latest calls open […]
14 January, 2019

AEMPS corrects its document on instructions for clinical trials in Spain

Source: The Spanish Agency for Medicines and Healthcare Products (AEMPS) has published the correction of errors of version 10 of the document of instructions for […]
8 January, 2019

A new refinement increases the safety of CAR-T therapy

Source: Bellicum Pharma has reported the preliminary results of its phase I / II dose escalation study in 12 patients with metastatic pancreatic cancer treated […]
26 December, 2018

Investigations of the Carlos III National Center for Cardiovascular Research

Source: The studies published by the CNIC scientists during the year 2017 consolidate this center as an institution of Spanish and international research excellence, highlighting […]
20 December, 2018

New method for the prediction of response to treatment in clinical trials

Source: Researchers from the universities of Vienna and Lancaster have developed a method aimed at improving precision medicine already during the clinical development phase of […]
14 December, 2018

Combining metformin and an antihypertensive is effective against tumors

Source: A common medication for diabetes, combined with a drug against high blood pressure, is able to inhibit the growth of tumorese induce the death […]
12 December, 2018

Advances in therapies directed to lymphocytes in systemic lupus erythematosus

Source: Systemic lupus erythematosus (SLE) is an autoimmune disease with multifaceted and extremely variable clinical manifestations, characterized by relapses and outbreaks followed by periods of […]
4 December, 2018

More than 130,000 patients participate in 3,000 clinical trials in Spain

Source: Spain has become the second country in the world where more clinical trials are carried out, only surpassed by the United States, the hegemonic […]
29 November, 2018

Farma-Biotech promotes nine projects on innovative drugs

Source: Different Spanish biotechnology companies and research groups presented on Wednesday a total of nine advanced innovative drug development projects to representatives of 17 national […]
22 November, 2018

INCLIVA shows the possible improvement of atherosclerosis through a molecule

Source: Researchers from the Health Research Institute of the Hospital Clínico de Valencia (INCLIVA) have shown that a molecule used to treat cancer, called PD033299, […]
20 November, 2018

Novartis works with 50 molecules in the development of new CART therapies

Source: The great results obtained with CAR-T therapies in cancer patients in whom chemotherapy has failed have focused the day ‘Towards a greater knowledge of […]